Independent information. England-wide.Public data. Clear sources.

NCT05776069

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

Registered research study with 5 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Von Willebrand Diseases
Lead sponsor
Vega Therapeutics, Inc
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
12 Years to 60 Years
Sex eligibility field
All
Healthy volunteers accepted
Yes, subject to the full eligibility criteria
Phase
Phase1, Phase2
Study record last updated
26 August 2025
Study team last verified status
2025-08

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Queen Elizabeth Hospital Birmingham

Birmingham · B15 2TT

RecruitingCare in Birmingham

England postcode

University Hospital Southampton NHS Foundation Trust

Southampton · SO16 6YD.

RecruitingEngland location

Source location point within ONS England boundary

Royal Free Hospital

London · NW3 2QG

RecruitingCare in Camden

England postcode

Royal London Hospital, Clinical Haematology Research

Whitechapel · E12ES

RecruitingCare in Tower Hamlets

England postcode

Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital

London

RecruitingEngland location

Source location point within ONS England boundary

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.